Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05629416 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Communicate Study Partnership

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 16, 2023 (before its estimated May 11, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Re-verified, no change to tracked fieldsv2
  2. Minor Study First Submitted
The vision of the Communicate Study Partnership is to ensure more Aboriginal patients receive culturally safe healthcare in their first language. The Communicate Study Partnership will implement and evaluate creative ways to embed cultural safety training and increase use of Aboriginal Interpreters and Aboriginal Health Practitioners at Northern Territory Top End hospitals. Quantitative outcomes (interpreter uptake, outcomes including leave against medical advice, costs) will be measured using time-series analysis. Qualitative outcomes derived from interviews with patient, healthcare provider and interpreter participants, will be informed by decolonising theory and participatory approaches. Successful project implementation will improve experience of care and health outcomes for Aboriginal people, build Aboriginal workforce, and improve healthcare provider satisfaction.
Trial Details
NCT Number NCT05629416
Lead Sponsor Menzies School of Health Research
Collaborators: Northern Territory of Australia as represented by the Department of Health, Djalkiri Foundation Aboriginal Corporation, Charles Darwin University, National Accreditation Authority for Translators and Interpreters, Northern Territory Government as represented by the Department of The Chief Minister and Cabinet
Conditions
(from sponsor)
Aboriginal Health, Cultural Safety, Access to Interpreters, Healthcare Provider Training
Enrollment 340 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov